Shares of Usana Health Sciences (USNA) surged 5.13% on Tuesday, despite the company reporting mixed results for the third quarter of 2024.
Usana, a leading manufacturer of nutritional products and supplements, posted adjusted earnings per share of $0.56 for the quarter ended September 30, 2024. This figure exceeded Wall Street's expectations of $0.49 per share and marked a slight improvement over the same period last year when the company reported EPS of $0.59.
However, the company's revenue fell short of analysts' projections, declining 6.2% year-over-year to $200.22 million. Analysts had anticipated revenue of $205.77 million. Despite the top-line miss, Usana's net income for the quarter stood at a respectable $10.61 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.